Int J Biol Sci 2022; 18(3):1051. doi:10.7150/ijbs.69329 This issue Cite

Erratum

TRIM59 Is a Novel Marker of Poor Prognosis and Promotes Malignant Progression of Ovarian Cancer by Inducing Annexin A2 Expression : Erratum

You Wang1,2*, Zhicheng Zhou3*, Xinran Wang1,2*, Xuping Zhang4,5, Yansu Chen4,5, Jin Bai4,5✉, Wen Di1✉

1. Department of Obstetrics and Gynecology, Renji Hospital, School of Medicine, Shanghai Jiao Tong University, Shanghai 200001, China;
2. Shanghai Key Laboratory of Gynecologic Oncology, Focus Construction Subject of Shanghai Education Department, Shanghai;
3. Department of Molecular and Cellular Biology, Baylor College of Medicine, Houston, TX 77030, USA;
4. Cancer Institute, Xuzhou Medical University, Xuzhou 221002, Jiangsu Province, China;
5. Jiangsu Center for the Collaboration and Innovation of Cancer Biotherapy, Cancer Institute, Xuzhou Medical University, Xuzhou 221002, Jiangsu Province, China.
*These authors contributed equally to this work.

Citation:
Wang Y, Zhou Z, Wang X, Zhang X, Chen Y, Bai J, Di W. TRIM59 Is a Novel Marker of Poor Prognosis and Promotes Malignant Progression of Ovarian Cancer by Inducing Annexin A2 Expression : Erratum. Int J Biol Sci 2022; 18(3):1051. doi:10.7150/ijbs.69329. https://www.ijbs.com/v18p1051.htm
Other styles

File import instruction

Corrected-article in Int J Biol Sci, Volume 14, 2073


Citation styles

APA
Wang, Y., Zhou, Z., Wang, X., Zhang, X., Chen, Y., Bai, J., Di, W. (2022). TRIM59 Is a Novel Marker of Poor Prognosis and Promotes Malignant Progression of Ovarian Cancer by Inducing Annexin A2 Expression : Erratum. International Journal of Biological Sciences, 18(3), 1051. https://doi.org/10.7150/ijbs.69329.

ACS
Wang, Y.; Zhou, Z.; Wang, X.; Zhang, X.; Chen, Y.; Bai, J.; Di, W. TRIM59 Is a Novel Marker of Poor Prognosis and Promotes Malignant Progression of Ovarian Cancer by Inducing Annexin A2 Expression : Erratum. Int. J. Biol. Sci. 2022, 18 (3), 1051. DOI: 10.7150/ijbs.69329.

NLM
Wang Y, Zhou Z, Wang X, Zhang X, Chen Y, Bai J, Di W. TRIM59 Is a Novel Marker of Poor Prognosis and Promotes Malignant Progression of Ovarian Cancer by Inducing Annexin A2 Expression : Erratum. Int J Biol Sci 2022; 18(3):1051. doi:10.7150/ijbs.69329. https://www.ijbs.com/v18p1051.htm

CSE
Wang Y, Zhou Z, Wang X, Zhang X, Chen Y, Bai J, Di W. 2022. TRIM59 Is a Novel Marker of Poor Prognosis and Promotes Malignant Progression of Ovarian Cancer by Inducing Annexin A2 Expression : Erratum. Int J Biol Sci. 18(3):1051.

This is an open access article distributed under the terms of the Creative Commons Attribution License (https://creativecommons.org/licenses/by/4.0/). See http://ivyspring.com/terms for full terms and conditions.
Popup Image